Case number 1:23-cv-00892
AbbVie Inc. v. Zenara Pharma Private Limited et al > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Oct 18, 2023 | 7 | SO ORDERED Granting 6 Joint Stipulation of Dismissal without Prejudice (***Civil Case Terminated). Signed by Judge Richard G. Andrews on 10/18/2023. (nms) (Entered: 10/18/2023) (3) |
| Oct 18, 2023 | 8 | Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 11,542,239 B2. (Attachments: # 1 Order)(nms) (Entered: 10/18/2023) (0) |
| Oct 17, 2023 | 6 | JOINT Stipulation of Dismissal without Prejudice, by AbbVie Inc.. (Tigan, Jeremy) Modified on 10/17/2023 (nms). (Entered: 10/17/2023) (3) |
| Aug 16, 2023 | N/A | Case Assigned to Judge Richard G. Andrews. Please include the initials of the Judge (RGA) after the case number on all documents filed. Associated Cases: 1:23-cv-00881-RGA, 1:23-cv-00892-RGA (rjb) (Entered: 08/16/2023) (0) |
| Aug 11, 2023 | 1 | Complaint* (1) |
| Aug 11, 2023 | 2 | Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (apk) (Entered: 08/14/2023) (3) |
| Aug 11, 2023 | 3 | Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 6/29/2023. Date of Expiration of Patent: 7/23/2039.Thirty Month Stay Deadline: 1/23/2026. (apk) (Entered: 08/14/2023) (2) |
| Aug 11, 2023 | 4 | Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 11,542,239 B2. (apk) (Entered: 08/14/2023) (1) |
| Aug 11, 2023 | 5 | Disclosure Statement pursuant to Rule 7.1: No Parents or Affiliates Listed filed by AbbVie Inc. (apk) (Entered: 08/14/2023) (1) |
| Aug 11, 2023 | N/A | No Summons Issued. (apk) (Entered: 08/14/2023) (0) |
